Charles Schwab’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.8M | Buy |
1,056,019
+46,123
| +5% | +$645K | ﹤0.01% | 1825 |
|
|
2025
Q1 | $13.7M | Sell |
1,009,896
-18,566
| -2% | -$252K | ﹤0.01% | 1808 |
|
|
2024
Q4 | $21M | Buy |
1,028,462
+12,652
| +1% | +$258K | ﹤0.01% | 1676 |
|
|
2024
Q3 | $29.6M | Sell |
1,015,810
-43,494
| -4% | -$1.27M | 0.01% | 1466 |
|
|
2024
Q2 | $24.6M | Buy |
1,059,304
+18,245
| +2% | +$424K | ﹤0.01% | 1538 |
|
|
2024
Q1 | $21.4M | Buy |
1,041,059
+34,062
| +3% | +$699K | ﹤0.01% | 1571 |
|
|
2023
Q4 | $21.6M | Buy |
1,006,997
+25,938
| +3% | +$557K | 0.01% | 1552 |
|
|
2023
Q3 | $20.2M | Buy |
981,059
+113,428
| +13% | +$2.34M | 0.01% | 1506 |
|
|
2023
Q2 | $25.6M | Buy |
867,631
+31,303
| +4% | +$924K | 0.01% | 1314 |
|
|
2023
Q1 | $19.3M | Sell |
836,328
-345
| -0% | -$7.95K | 0.01% | 1503 |
|
|
2022
Q4 | $23.3M | Buy |
836,673
+105,793
| +14% | +$2.94M | 0.01% | 1331 |
|
|
2022
Q3 | $22.4M | Sell |
730,880
-642
| -0.1% | -$19.7K | 0.01% | 1284 |
|
|
2022
Q2 | $21.5M | Buy |
731,522
+27,271
| +4% | +$803K | 0.01% | 1354 |
|
|
2022
Q1 | $22.7M | Sell |
704,251
-12,939
| -2% | -$416K | 0.01% | 1442 |
|
|
2021
Q4 | $32M | Buy |
717,190
+13,438
| +2% | +$599K | 0.01% | 1216 |
|
|
2021
Q3 | $35.5M | Buy |
703,752
+63,518
| +10% | +$3.2M | 0.01% | 1099 |
|
|
2021
Q2 | $50.2M | Buy |
640,234
+74,718
| +13% | +$5.86M | 0.02% | 865 |
|
|
2021
Q1 | $32.3M | Buy |
565,516
+72,318
| +15% | +$4.13M | 0.01% | 1133 |
|
|
2020
Q4 | $41.3M | Buy |
493,198
+6,758
| +1% | +$566K | 0.02% | 896 |
|
|
2020
Q3 | $17.4M | Buy |
486,440
+15,194
| +3% | +$544K | 0.01% | 1300 |
|
|
2020
Q2 | $11.4M | Buy |
471,246
+52,574
| +13% | +$1.27M | 0.01% | 1563 |
|
|
2020
Q1 | $7.33M | Buy |
418,672
+44,194
| +12% | +$774K | ﹤0.01% | 1633 |
|
|
2019
Q4 | $6.52M | Buy |
374,478
+7,203
| +2% | +$125K | ﹤0.01% | 1887 |
|
|
2019
Q3 | $5.63M | Buy |
367,275
+14,153
| +4% | +$217K | ﹤0.01% | 1905 |
|
|
2019
Q2 | $7.33M | Buy |
353,122
+14,475
| +4% | +$301K | ﹤0.01% | 1778 |
|
|
2019
Q1 | $7.86M | Buy |
338,647
+16,383
| +5% | +$380K | 0.01% | 1732 |
|
|
2018
Q4 | $6.66M | Sell |
322,264
-2,577
| -0.8% | -$53.2K | 0.01% | 1725 |
|
|
2018
Q3 | $7.06M | Buy |
324,841
+245,312
| +308% | +$5.33M | ﹤0.01% | 1857 |
|
|
2018
Q2 | $1.21M | Buy |
79,529
+13,323
| +20% | +$203K | ﹤0.01% | 2525 |
|
|
2018
Q1 | $1.3M | Buy |
+66,206
| New | +$1.3M | ﹤0.01% | 2443 |
|